Strategies for managing cytomegalovirus in transplant recipients. - Wikidata - awgldk - TriplyDB

Strategies for managing cytomegalovirus in transplant recipients.

Strategies for managing cytomegalovirus in transplant recipients.

http://www.wikidata.org/entity/Q37773992

about

Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm Unraveling the Role of Allo-Antibodies and Transplant Injury Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes Congenital cytomegalovirus infection: new prospects for prevention and therapy Cytomegalovirus infections in solid organ transplantation: a review.Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application.Cytomegalovirus infection in lung transplant recipients.Human herpesvirus vaccines and future directions.Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.

P2860

Q26850340-0CA3B2FA-481E-4780-A9D1-B57E6DFEC36E Q28069336-4CA9687C-5098-4056-9424-490EF84AD22A Q33858240-63ED13C1-9AD0-4A0E-A4B3-9BA73A26050C Q37254183-21A7BDF8-F0BD-4FDE-A629-88651C36E7F1 Q37359332-70ECF506-0614-4FC2-9A18-E0B445BC7812 Q37967604-8021E2B0-86A8-4280-B20D-4497CE21E9E3 Q39226830-518F2625-675B-407F-86FF-48E964001E23 Q39476453-67F6326F-20B5-4B3B-83CB-75EB1237616D Q40779366-2E10FF4A-2531-48F1-B26C-3E781429C3BB Q41052120-4858047B-828E-46F9-9EA4-87BCE5B1C3DA Q43523397-A81931C9-F759-4DFB-81BA-AAB650BD94E4

P2860

Strategies for managing cytomegalovirus in transplant recipients.

http://www.wikidata.org/entity/Q37773992

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Strategies for managing cytomegalovirus in transplant recipients.

@en

Strategies for managing cytomegalovirus in transplant recipients.

@nl

type

label

Strategies for managing cytomegalovirus in transplant recipients.

@en

Strategies for managing cytomegalovirus in transplant recipients.

@nl

prefLabel

Strategies for managing cytomegalovirus in transplant recipients.

@en

Strategies for managing cytomegalovirus in transplant recipients.

@nl

P1433

Q37773992-799026DC-6FD2-4ACB-8073-D7BFBBC77DE8

P1476

Q37773992-C3E1D6BC-0118-4D5F-895C-E5B7537B6B19

P2093

Q37773992-BBC014E5-9601-4A49-855C-1D31732BD66D

P2860

Q37773992-04E50E8D-11FD-479F-99CA-5CF6340EA233

Q37773992-06EFAC97-771D-452A-A7C4-B5A06190B72A

Q37773992-087E34F4-72D6-402F-8C71-AFB6DE119527

Q37773992-0BF0143D-9D35-4C1B-9D31-C9437FFB8EBB

Q37773992-0C095390-8954-4DAE-A39D-87CE12E798E1

Q37773992-0F031CFD-52F5-48F0-9D42-3C442ED95A6E

Q37773992-0F3DA4A4-F892-4D2A-A063-B4DDB9F43346

Q37773992-12EB9DAB-BEB9-462C-87D1-BB037440635C

Q37773992-14A917B7-A1A6-4E58-836B-CC81F782EB02

Q37773992-1EE2B366-9B58-4A30-A3A2-73A77BD05A20

P304

Q37773992-E04472E2-0C3D-4D75-9C75-311A8F9F60ED

P31

Q37773992-F154C13C-C0E9-431E-AC4C-EE4EDF9D6C95

P356

Q37773992-EE209C01-BB79-491B-84E2-F1E8793C7570

P407

Q37773992-5A447B1A-BFFD-4C67-BC69-67FBA5E5671A

P433

Q37773992-BFEE4676-66DD-4BE0-AD4F-DDDB01B5BBA9

P478

Q37773992-16504988-E558-45EC-B4FF-C364BAAC86D9

P577

Q37773992-AA1C21DF-1D12-49A0-9D3D-3DD9AB6FCD2D

P698

Q37773992-2818A81A-C06B-4A36-B097-00D0F529A703

P921

Q37773992-5A88402D-CE95-4BA7-856B-6CE8A0583B03

P356

14656566.2010.492395

P1433

Expert Opinion on Pharmacotherapy

P1476

Strategies for managing cytomegalovirus in transplant recipients.

@en

P2093

Raymund R Razonable

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine prevention of maternal cytomegalovirus infection

The dynamics of human cytomegalovirus replication in vivo

Definitions of cytomegalovirus infection and disease in transplant recipients

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.

Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.

The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation.

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy.

P304

1983-1997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2010.492395

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20642369

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus